LFST (LifeStance Health Group) Ending Cash Position: $195 Mil (As of Mar. 2026)


LFST LifeStance Health Group Inc LFST
56 GF Score
Price $10.71
GF Value $8.23
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is LifeStance Health Group Ending Cash Position?

LifeStance Health Group LFST +3.58% 56 Ending Cash Position is $195 Mil as of Mar. 2026. GuruFocus rates LFST with a GF Score™ of 56/100 and a GF Value™ of $8.23 (Significantly Overvalued). The stock has 5 warning signs investors should review.

LifeStance Health Group's Ending Cash Position for the quarter that ended in Mar. 2026 was $195 Mil.

LifeStance Health Group's quarterly Ending Cash Position increased from Sep. 2025 ($204 Mil) to Dec. 2025 ($249 Mil) but then declined from Dec. 2025 ($249 Mil) to Mar. 2026 ($195 Mil).

LifeStance Health Group's annual Ending Cash Position increased from Dec. 2023 ($79 Mil) to Dec. 2024 ($155 Mil) and increased from Dec. 2024 ($155 Mil) to Dec. 2025 ($249 Mil).

LifeStance Health Group Ending Cash Position Related Terms

LifeStance Health Group Ending Cash Position Historical Data

* Premium members only.

The historical data trend for LifeStance Health Group's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LifeStance Health Group Ending Cash Position Chart

LifeStance Health Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 148.03 108.62 78.82 154.57 248.64

LifeStance Health Group Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 134.34 188.93 203.90 248.64 194.80
LFST
56GF Score
LifeStance Health Group Inc LFST
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

LifeStance Health Group Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

LifeStance Health Group's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=154.571+94.071
=249

LifeStance Health Group's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=248.642+-53.845
=195

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $195 Mil mean?
LifeStance Health Group (LFST) has a Ending Cash Position of $195 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on LifeStance Health Group and its competitors.
Is LifeStance Health Group's Ending Cash Position too high?
LifeStance Health Group's current Ending Cash Position is $195 Mil. Overall, LifeStance Health Group has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Ending Cash Position compare to CON and BKD?
LifeStance Health Group's Ending Cash Position of $195 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on LifeStance Health Group and its competitors. LifeStance Health Group's current Ending Cash Position is $195 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Significantly Overvalued. The stock's GF Value™ is $8.23, compared to a current price of $10.71 — trading 30.1% above its estimated fair value. The current Ending Cash Position is $195 Mil. LifeStance Health Group's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Ending Cash Position is $195 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is LifeStance Health Group (LFST) Overvalued in 2026?

Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued. The current stock price of $10.71 is trading 30.1% above its estimated GF Value™ of $8.23. GuruFocus considers LifeStance Health Group to be Significantly Overvalued.

Key valuation signals for LFST:

  • Ending Cash Position: $195 Mil
  • GF Value™: $8.23 vs. price of $10.71 (30.1% above fair value)
  • GF Score™: 56/100 with 5 warning signs

No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

LifeStance Health Group Business Description

Address 4800 North Scottsdale Road, Suite 2500, Scottsdale, AZ, USA, 85251
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
56GF Score

Get the complete analysis for LFST

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.71
Price
$8.23
GF Value